10 clinical trial consultants
Clinical trial consultants with very different backgrounds sit here: two held SVP or VP clinical operations titles at Verismo Therapeutics, Kadmon and Noema Pharma, others list trial roles at Eli Lilly, Merck Healthcare, Parexel and PPD, one is a physician focused on device and regenerative medicine studies, and three have held consulting titles since 2002 or 2003. That spread helps a small biotech plan a first study, pick and oversee a CRO, or prepare for an FDA inspection.
Professionals to explore
Andrew McGinn
LinkedInExperience: Consultant Associate Director Senior Global Clinical Trial Manager · McGinn Clinical Consultants, LLC
At McGinn Clinical Consultants, LLC since 2002, Andrew McGinn helps biotech and pharma teams move oncology, rare disease and specialty programs from protocol concept to NDA, with CRO/vendor oversight and RBQM named as strengths. Earlier roles were Associate Director, Project Management at Parexel International (2002) and Clinical Research Manager at DuPont Pharmaceuticals (1995–2001), so CRO oversight questions fit well.
Is this you? Claim your profile and get paid for calls.
Jane Knudson
LinkedInExperience: Clinical Development and Operations Consultant · Knudson Associates, LLC
Clinical Development and Operations Consultant at Knudson Associates, LLC since 2003, Jane Knudson has taken Clinical Consultant engagements at KaloBios (2010–2011), InterMune (2009–2010), FibroGen (2009) and Talima Therapeutics (2008–2009). Jane Knudson describes 20+ years across drugs, biologics, drug-device combinations and diagnostics, directing research from protocol development through final report on large CRO-run projects.
Is this you? Claim your profile and get paid for calls.
Jennifer Stillman
LinkedInExperience: Clinical Trial Consultant · Stillman Clinical Solutions
Jennifer Stillman founded Stillman Clinical Solutions and has worked as its Clinical Trial Consultant since June 2026, helping sponsors and biotechs build, launch and scale clinical programs, and cites 20+ years leading global Phase I–IV programs across pharma, CRO and site network settings. Recent roles include Strategic Delivery Director at Flourish Research (2025–2026), Sr. Director, Strategic Feasibility at Caidya (2022–2025) and Associate Director, Global Site Intelligence and Activation at PPD (2016–2021).
Is this you? Claim your profile and get paid for calls.
Lisa Gott
LinkedInExperience: Independent Clinical Operations Consultant · Gott Clinical Trial Consultants, LLC
Independent Clinical Operations Consultant at Gott Clinical Trial Consultants, LLC since 2016, Lisa Gott provides clinical operations and medical-clinical affairs support to pharma, biotech and medical device clients, including clinical-stage companies with limited staff. Lisa Gott was also Clinical Operations Lead (Independent Consultant) at Lyric Pharmaceuticals (2017–2018) and a Rare Disease Clinical Trial Educator at Alexion on assignment from Quintiles (2014–2016).
Is this you? Claim your profile and get paid for calls.
Meredith Schiller
LinkedInExperience: Independent Clinical Development Consultant · Meredith Schiller Consulting
Study design, vendor oversight, GCP auditing, US and EU regulatory submissions and BIMO inspections are among the areas Meredith Schiller lists as an Independent Clinical Development Consultant since 2020. Before that came Clinical Operations Consultant at BioBridges (2015–2020), Director Clinical Operations at Acceleron Pharma (2014–2015) and Director, Clinical Operations at Collegium Pharmaceutical (2008–2011), useful when preparing a program for inspection.
Is this you? Claim your profile and get paid for calls.
Mikhail Chkolnik, MD
LinkedInExperience: Principal Consultant, Clinical Research & Trial Execution · Self-employed / Chkolnik Consulting LLC
Principal Consultant, Clinical Research & Trial Execution at Chkolnik Consulting LLC since April 2026, Mikhail Chkolnik, MD advises on trial strategy and execution for early-stage programs in orthopedic devices, regenerative medicine and translational biotech, where design choices shape data quality. The prior role was Associate Director, Clinical Operations at Vericel Corporation (2021–2026), after Senior Manager, Medical Safety at Akros Pharma (2019–2021).
Is this you? Claim your profile and get paid for calls.
Sara Weiss
LinkedInExperience: Senior Clinical Operations Consultant · SWW Clinical Consulting
Sara Weiss has been a Senior Clinical Operations Consultant at SWW Clinical Consulting since 2002 and held Senior Vice President Clinical Operations titles at Verismo Therapeutics (2021–2024), Syntimmune (2015–2017) and Kadmon (2011–2015). Sara Weiss describes 26 years taking drugs and biologics through all trial stages and FDA approval, building teams and running large and small trials at domestic and international sites.
Is this you? Claim your profile and get paid for calls.
Shelly Bustion-Diab
LinkedInExperience: Self-employed, freelance clinical operations expert · Bliss Consulting Sàrl
Since 2013, Shelly Bustion-Diab has been a self-employed clinical operations expert through Bliss Consulting Sàrl, working with pharma, academia and CROs, and a Coordinator and Lecturer at the University of Geneva since 2011. Merck Healthcare roles as Director, Site Head Geneva, Clinical Trial Management Early Development (2011–2012) and Associate Director, Clinical Trial Management Early Development (Ph I to POC) (2009–2011) fit early-phase questions.
Is this you? Claim your profile and get paid for calls.
Simon Roitt
LinkedInExperience: Consultant Clinical Development and Clinical Operations · Freelance
A freelance Consultant Clinical Development and Clinical Operations since 2024, Simon Roitt was VP Head of Clinical Operations (2021–2024) and Program Development Leader (2022–2024) at Noema Pharma, and Director Clinical Program Operations at Eli Lilly and Company (2019–2021). With a D.Phil and 25+ years in clinical research, Simon Roitt names clinical program and study management and vendor oversight as strengths.
Is this you? Claim your profile and get paid for calls.
Tania Johnstone Issa
LinkedInExperience: Independent Consultant in Clinical Trials Operations, Technologies, & Compliance · Seattle WA, Self Employed
Tania Johnstone Issa has worked since 2008 as an Independent Consultant in Clinical Trials Operations, Technologies, & Compliance and as a Consultant at Insite QA, with 15+ years across global clinical research operations and GCP compliance in Phase I–IV trials for devices, biologics and drugs. Earlier roles were Global Director of Operations at OSI Systems (2005–2008) and Clinical Research Consultant at Clinimetrics (1994–1999).
Is this you? Claim your profile and get paid for calls.
Choose the right perspective
For a first study at a small biotech, the three with past SVP, VP or director clinical operations titles, Sara Weiss, Simon Roitt and Meredith Schiller, can help size the team and budget, and Lisa Gott describes supporting clinical-stage companies with few staff. CRO selection and oversight fit Andrew McGinn, Jane Knudson and Jennifer Stillman, whose records cover vendor oversight, CRO-run studies and site feasibility; pick Tania Johnstone Issa for GCP compliance, Mikhail Chkolnik, MD for device and regenerative medicine trials, and Shelly Bustion-Diab for early development (Ph I to POC).
Questions to take into the conversation
- 01For a first Phase 1 study, which clinical operations roles should a small biotech hire in-house and which can a CRO or consultant cover?
- 02How do you pick a CRO for a first trial, and what oversight keeps its timelines and budget from drifting?
- 03What do small sponsors most often miss when preparing for an FDA inspection of their first clinical program?
About this directory
This is a professional research starting point based on business profile data retrieved on . Titles and companies reflect that source snapshot; roles marked former had ended by then. Check the linked profiles for current details. Inclusion does not imply Instant Expert membership or availability.